Skip to main content
MS-DRG 829 · MDC 17 · Surgical

MS-DRG 829: Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 829

FY2027 relative weight
3.1281
Higher than 78% of all MS-DRGs
Change vs FY2026
-1.0%
FY2026 weight 3.1600
Geometric mean LOS
5.6 days
Arithmetic mean 8.3 days
MDC
17
Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
Severity level
with CC (complication or comorbidity)
National unadjusted operating payment
$21,421.23
Weight × $6,848.00 FY2027 standardized amount; capital adds $1,689.02
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 829 is a surgical group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms), at the higher of two severity levels (a CC or an MCC is present). CMS assigns it a FY2027 relative weight of 3.1281 with a geometric mean length of stay of 5.6 days and an arithmetic mean of 8.3. Its weight moved down 1.0% from FY2026 (3.1600). That weight is higher than 78% of all MS-DRGs. Its weight sits 110.5% above DRG 830 (without CC/MCC, 1.4859). The v44 Definitions Manual assigns it through 114 myeloproliferative disorders or poorly differentiated neoplasms (principal diagnosis) codes and 189 non-operating room procedures codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 829 the FY2027 relative weight is 3.1281 against 3.1600 in FY2026, a fall of 1.01%.

FY2026 versus FY2027 payment factors for MS-DRG 829
MetricFY2026FY2027Change
Relative weight3.16003.1281-0.0319
Geometric mean LOS (days)5.95.6-0.3
Arithmetic mean LOS (days)9.08.3-0.7
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 829 shares its base definition with 1 other MS-DRG split by severity. The family's weights span 1.4859 to 3.1281, a 2.11× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 829
DRGTitleFY2027 weightGMLOSNational operating payment
829Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC3.12815.6$21,421.23
830Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC1.48592.0$10,175.44

At the national rate, documenting the family's top severity level (DRG 829, $21,421.23) instead of its base level (DRG 830, $10,175.44) changes the operating payment by $11,245.79, the amount at stake when a reviewer removes the MCC or CC that put the stay here. The figures are national operating amounts before the hospital-specific adjustments described below.

National unadjusted payment for DRG 829

Multiplying the FY2027 relative weight (3.1281) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $11,245.79.

FY2027 national unadjusted IPPS payment for MS-DRG 829
ComponentNational rateDRG 829
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$21,421.23
Capital (federal rate)$539.95$1,689.02
Operating plus capital$23,110.25
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $20,751.16 to $21,253.72 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 829.

Risk-adjusting diagnoses in this DRG

Appendix B of the v44 Definitions Manual lists 114 ICD-10-CM codes in the logic for DRG 829; 34 of them also map to a CMS-HCC V28 payment category, across 7 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.

CMS-HCC V28 categories among the diagnoses in the logic for DRG 829
V28 HCCCategoryShared codesExamples
HCC 23Prostate, Breast, and Other Cancers and Tumors14C76.40, C76.41, C76.42
HCC 21Lymphoma and Other Cancers7C37, C7A.00, C7A.091
HCC 17Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic4C7B.00, C7B.09, C7B.1
HCC 18Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid3C79.89, C79.9, C80.0
HCC 22Bladder, Colorectal, and Other Cancers3D3A.00, D3A.098, D3A.8
HCC 19Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers2C45.7, C45.9
HCC 20Lung and Other Severe Cancers1C48.0

New for FY2027: codes that group to DRG 829

IPPS Tables 6A and 6B assign 1 new ICD-10-CM code to DRG 829 from October 1, 2026. Encoders and edit tables that still run the v43 code set reject these codes or group them elsewhere, so check them first when a FY2027 discharge in this DRG fails an edit. The FY2027 ICD-10 code-change report lists every addition and deletion with its CC level and MS-DRGs.

New FY2027 ICD-10-CM codes that group to DRG 829
ICD-10-CMDescriptionSeverity
C79.83Secondary malignant neoplasm of oral cavityCC

Grouper logic (v44 Definitions Manual)

The manual's split table for Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures gives one row per combination of criteria and the MS-DRG it assigns. DRG 829 is the row where CC or MCC is Yes.

Split table for Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures
CC or MCCDRG
Yes829
No830

Criteria stated in the manual

  • Any other operating room procedure not listed in DRGs 826-828
  • Any of the following non-operating room procedures

Myeloproliferative Disorders or Poorly Differentiated Neoplasms (Principal Diagnosis): 114 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.

Myeloproliferative Disorders or Poorly Differentiated Neoplasms (Principal Diagnosis) codes in the logic for DRG 829 (sample)
ICD-10-CM codeDescription
C37Malignant neoplasm of thymus
C45.7Mesothelioma of other sites
C45.9Mesothelioma, unspecified
C48.0Malignant neoplasm of retroperitoneum
C76.40Malignant neoplasm of unspecified upper limb
C76.41Malignant neoplasm of right upper limb
C76.42Malignant neoplasm of left upper limb
C76.50Malignant neoplasm of unspecified lower limb
C76.51Malignant neoplasm of right lower limb
C76.52Malignant neoplasm of left lower limb
C76.8Malignant neoplasm of other specified ill-defined sites
C79.83Secondary malignant neoplasm of oral cavity

Non-Operating Room Procedures: 189 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown. The manual joins this list to the one before it with "or".

Non-Operating Room Procedures codes in the logic for DRG 829 (sample)
ICD-10-PCS codeDescription
D020DZZStereotactic Other Photon Radiosurgery of Brain
D020HZZStereotactic Particulate Radiosurgery of Brain
D020JZZStereotactic Gamma Beam Radiosurgery of Brain
D021DZZStereotactic Other Photon Radiosurgery of Brain Stem
D021HZZStereotactic Particulate Radiosurgery of Brain Stem
D021JZZStereotactic Gamma Beam Radiosurgery of Brain Stem
D026DZZStereotactic Other Photon Radiosurgery of Spinal Cord
D026HZZStereotactic Particulate Radiosurgery of Spinal Cord
D026JZZStereotactic Gamma Beam Radiosurgery of Spinal Cord
D027DZZStereotactic Other Photon Radiosurgery of Peripheral Nerve
D027HZZStereotactic Particulate Radiosurgery of Peripheral Nerve
D027JZZStereotactic Gamma Beam Radiosurgery of Peripheral Nerve

Code editor, HAC and CC/MCC exclusion notes for DRG 829

Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.

The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 829; these are the ones that are also on a Medicare Code Editor list and can draw that edit.

Medicare Code Editor v44 lists that include codes in the logic of DRG 829
MCE editListCodesExamples
Edit 9unacceptable principal diagnosis63C80.2, Z08, Z85.00

Documentation and denial exposure

As a surgical DRG, assignment depends on a qualifying operating-room procedure being coded from the operative report; a missing or non-OR procedure code drops the stay into a medical DRG in MDC 17 with a lower weight. The inpatient claim reports that procedure in ICD-10-PCS, which NCCI does not edit; the surgeon's professional claim for the same operation carries CPT and HCPCS codes, and the NCCI pair checker for those professional codes shows whether two of them bundle. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 829

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 829

What is MS-DRG 829?

MS-DRG 829 is "Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC", a surgical Medicare Severity Diagnosis-Related Group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 829?

The FY2027 relative weight is 3.1281 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 3.1600, a change of -1.0%.

What is the Medicare base payment for MS-DRG 829?

$21,421.23 for operating costs plus $1,689.02 for capital, $23,110.25 together, at the FY2027 national rates: weight 3.1281 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 830 (without CC/MCC) comes to $10,175.44 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 829?

CMS reports a geometric mean length of stay of 5.6 days and an arithmetic mean of 8.3 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 829?

DRG 830 (without CC/MCC, weight 1.4859, GMLOS 2.0 days). Together with DRG 829 the family spans 1.4859 to 3.1281, a 2.11x spread, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 829?

DRG 829 is the upper level of a two-way split: the stay needs at least one secondary diagnosis on either the CMS CC list or the MCC list that is not excluded for this principal diagnosis. A CC and an MCC pay the same here, so the audit question is only whether one qualifying condition is documented by the treating clinician and shown to be monitored, evaluated or treated; a problem-list entry without assessment is the usual reason the stay drops to the base DRG.

Which codes group to DRG 829?

The v44 Definitions Manual lists 114 myeloproliferative disorders or poorly differentiated neoplasms (principal diagnosis) codes and 189 non-operating room procedures codes for this group. Examples from the myeloproliferative disorders or poorly differentiated neoplasms (principal diagnosis) list, C37 (Malignant neoplasm of thymus); C45.7 (Mesothelioma of other sites); and from the non-operating room procedures list, D020DZZ (Stereotactic Other Photon Radiosurgery of Brain); D020HZZ (Stereotactic Particulate Radiosurgery of Brain).

Is DRG 829 a post-acute transfer DRG?

No. DRG 829 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.